FRIENDSWOOD, Texas, March 15, 2024--Castle announces new data highlighting its IDgenetix PGx test in guiding medication recommendations for patients 65+ with mental health conditions.
FRIENDSWOOD, Texas, March 12, 2024--Castle Biosciences’ executive management will present a company overview at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
FRIENDSWOOD, Texas, March 08, 2024--Castle Biosciences announces it will share data across its dermatologic portfolio of gene expression profile tests at the 2024 AAD Annual Meeting.